AtriCure CFO Sees 12%-14% Organic Growth in 2026 as Pain Management Adoption Accelerates [Yahoo! Finance]
AtriCure, Inc. (ATRC)
Last atricure, inc. earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.atricure.com
Company Research
Source: Yahoo! Finance
to lead growth while hybrid Afib remains a headwind (but with a smaller decline than in 2025). The EnCompass clamp has shortened open ablation from ~30–45 minutes to 8–10 minutes, boosting concomitant Afib treatment in CABG and lifting U.S. CABG penetration from under 10% to about 20% by the end of 2025. AtriCure is pushing pain-management adoption via faster cryo tools (now ~one minute per nerve) and a new cryoXT indication for post-amputation pain in a U.S. market of ~180,000 amputations annually, though reimbursement remains a key headwind. Interested in AtriCure, Inc.? Here are five stocks we like better. AtriCure (NASDAQ:ATRC) CFO Angie Wirick outlined the company's early expectations for 2026 growth and discussed product adoption trends across its cardiac surgery and pain management franchises during an appearance at the Citizens Life Sciences Conference. Initial 2026 outlook: 12% to 14% organic growth Wirick said the company's initial 2026 organic revenue growth gui
Show less
Read more
Impact Snapshot
Event Time:
ATRC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ATRC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ATRC alerts
High impacting AtriCure, Inc. news events
Weekly update
A roundup of the hottest topics
ATRC
News
- AtriCure to Participate in the Citizens Life Sciences Conference [Yahoo! Finance]Yahoo! Finance
- AtriCure to Participate in the Citizens Life Sciences ConferenceBusiness Wire
- AtriCure (NASDAQ:ATRC) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.MarketBeat
- AtriCure (NASDAQ:ATRC) was given a new $53.00 price target on by analysts at Canaccord Genuity Group Inc..MarketBeat
- AtriCure (NASDAQ:ATRC) was given a new $55.00 price target on by analysts at UBS Group AG.MarketBeat
ATRC
Earnings
- 2/17/26 - Beat
ATRC
Sec Filings
- 3/12/26 - Form 144
- 3/12/26 - Form 4
- 3/9/26 - Form 4
- ATRC's page on the SEC website